Sugar-based Excipients Market 2022 Industry Research, Segmentation, Key Players Analysis and Forecast to 2033
As of 2033, the global sugar-based
excipients market is valued at US$ 1068.41 million, growing at a CAGR
of 4.8%. In 2023, the market was valued at US$ 1707.46 million. This rise in
market value is due primarily to the increased use of combination-processed
excipients.
It is anticipated that the rapid growth of the global
generics market due to the patent expiration of several blockbuster drugs, as
well as the increasing development of orally disintegrating tablets (ODTs) will
propel the growth of this market. Co-processed excipients are used to enhance
the dissolution, bioavailability, and solubility of recently developed active
pharmaceutical ingredients (APIs).
A growing market for orally disintegrating tablets is
booming as their popularity and development grow. Unlike traditional tablets,
orally disintegrating tablets dissolve on the tongue instead of being swallowed
whole. As the number of elderly and pediatric patients increases, so does the
need for orally disintegrating tablets.
“Increasing utilization of co-processed excipients,
patent cliffs for sugar excipients, and advancements in orally disintegrating
tablets (ODTS) are factors driving sugar-based excipients market growth.” says
a lead analyst at Future Market Insights.
Key Takeaways from Market Study
- The
sugar-based excipients market is expected to grow at a CAGR of 4.8% over
the forecast period.
- According
to estimates, the sugar-based excipients market in North America will
remain strong throughout the length of the forecast period.
- In
terms of type, the powder segment accounts for a significant share of the
market since it is widely used in pharmaceutical applications.
- The
actual sugar segment is projected to reach a revenue share of US$ 750.5
million by 2033 and is expected to expand at a CAGR of 4.4%.
- The
U.S. sugar-based excipients market is expected to record a CAGR of 3.5%
during the forecast period.
- China’s
sugar-based excipients market is projected to reach revenues of US$ 258.5
million by 2033. This is expected to deliver the fastest CAGR of 6.7%.
Competitive Landscape:
Several prominent companies dominate this market,
including Ashland Inc., Associated British Foods Plc, BASF SE,
Colorcon, Inc., Cargill, Inc., DFE Pharma, FMC Corporation, MEGGLE AG, Roquette
Group, and The Lubrizol Corporation and others.
Excipient companies engage in a variety of key activities,
including product launches, expansions, and distribution network expansions, as
well as establishing global footprints through subsidiaries and partnerships.
Using these activities, manufacturers can gain a larger
share of the market, expand their product portfolios, and expand their reach to
different regions. They can also gain access to new markets and advanced
technologies through partnerships with other companies. Major players also
acquire companies, merge, and diversify their portfolios.
Recent Developments:
- In
September 2022, Roquette acquired Crest Cellulose, an Indian company that
manufactures pharmaceutical and nutraceutical excipients. By acquiring
Crest Cellulose, Roquette is gaining access to a larger market and
expanding its portfolio of excipients. This acquisition gives Roquette a
more comprehensive range of excipients and allows Roquette to gain more
market share in India.
- In
July 2022, DFE Pharma introduced Lactohale 400, a lactose-free, non-GMO,
plant-based excipient that can be used in tablets, capsules, and granules.
It is a lactose-free, non-GMO, plant-based excipient. To meet the
increasing demand for natural, sustainable excipients in the nutraceutical
and pharmaceutical industries, the product was developed.
- The
Roquette Group (France) has developed a wide range of sugar-based
excipients that are proven to work in the industry. In Lestrem, France,
the Roquette Group opened a pharmaceutical application development center.
With this upgraded facility, the company was able to develop excipients
and active ingredients more effectively.
- For
the growing demand for excipient products as well as services in Shanghai,
China, DFE Pharma (Germany) opened a new sales office.
Sugar-based Excipients by Category
By Product, the Sugar-based Excipients Market is Segmented
as:
- Actual
Sugar
- Sugar
alcohols
- Artificial
sweeteners
By Type, the Sugar-based Excipients Market is Segmented as:
- Powders
- Direct
Compression Sugars
- Crystals
- Syrups
- Others
By Functionality, the Sugar-based Excipients Market is
Segmented as:
- Fillers
and Diluents
- Flavoring
Agents
- Tonicity
Agents
- Others
By Formulation, Sugar-based Excipients are Segmented as:
- Oral
- Parenteral
- Topical
- Others
By Region, Sugar-based Excipients are Segmented as:
- North
America
- Latin
America
- Europe
- The
Middle East and Africa
- East
Asia
Report Link: https://www.futuremarketinsights.com/reports/sugar-based-excipients-market
Comments
Post a Comment